Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169793 · ClinicalTrials.gov registry record · NA
Nephrolithiasis and Bariatric Surgery
A NA study, sponsored by Indiana Kidney Stone Institute.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT00169793: Completed NA study, sponsored by Indiana Kidney Stone Institute.
NCT00169793 is a NA study that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169793, a NA study, has completed, sponsored by Indiana Kidney Stone Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
Test the hypothesis that the new bariatric surgical procedures (BSP) increase stone risk, and will result in an increased incidence and prevalence of stone disease; the purpose is to determine if BSP patients require special management for stone prevention. This study does not include the bariatric surgery but enrolls subjects who are already scheduled for surgery with an affiliated surgeon. The study procedure is to collect 24 hour urines pre-and post surgically to evaluate the risk of kidney stone procedure after surgery.
Interventions
- OTHER evaluation of kidney stone risk after bariatric surgery
- OTHER Evaluate risk of kidney stones after bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2005-08 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT00169793 record still lists
NCT00169793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which evaluation of kidney stone risk after bariatric surgery is the first listed.
NCT00169793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00169793 about?
NCT00169793 is a clinical study titled "Nephrolithiasis and Bariatric Surgery". Test the hypothesis that the new bariatric surgical procedures (BSP) increase stone risk, and will result in an increased incidence and prevalence of stone disease; the purpose is to determine if BSP patients require special management for stone prevention. This study does not include the bariatric ...
What is the current status of trial NCT00169793?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2005-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00169793?
The interventions under investigation include: evaluation of kidney stone risk after bariatric surgery (OTHER), Evaluate risk of kidney stones after bariatric surgery (OTHER).
Who is sponsoring clinical trial NCT00169793?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00169793's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia